These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

167 related articles for article (PubMed ID: 39083798)

  • 1. Use of Transdermal Alcohol Sensors in Conjunction With Contingency Management to Reduce Alcohol Consumption in People With Alcohol Dependence Attending Alcohol Treatment Services: Protocol for a Pilot Feasibility Randomized Controlled Trial.
    Brobbin E; Deluca P; Parkin S; Drummond C
    JMIR Res Protoc; 2024 Jul; 13():e57653. PubMed ID: 39083798
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Comparison of transdermal alcohol concentration and self-reported alcohol consumption in people with alcohol dependence attending community alcohol treatment services.
    Brobbin E; Deluca P; Coulton S; Parkin S; Drummond C
    Drug Alcohol Depend; 2024 Mar; 256():111122. PubMed ID: 38367536
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A qualitative exploration of the experiences of transdermal alcohol sensor devices amongst people in receipt of treatment for alcohol use disorder.
    Brobbin E; Parkin S; Deluca P; Drummond C
    Addict Behav Rep; 2024 Jun; 19():100544. PubMed ID: 38596194
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Temporal Dynamics of Transdermal Alcohol Concentration Measured via New-Generation Wrist-Worn Biosensor.
    Fairbairn CE; Kang D
    Alcohol Clin Exp Res; 2019 Oct; 43(10):2060-2069. PubMed ID: 31469451
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Acceptability and validity of using the BACtrack skyn wrist-worn transdermal alcohol concentration sensor to capture alcohol use across 28 days under naturalistic conditions - A pilot study.
    Courtney JB; Russell MA; Conroy DE
    Alcohol; 2023 May; 108():30-43. PubMed ID: 36473634
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A preliminary randomized controlled trial of contingency management for alcohol use reduction using a transdermal alcohol sensor.
    Barnett NP; Celio MA; Tidey JW; Murphy JG; Colby SM; Swift RM
    Addiction; 2017 Jun; 112(6):1025-1035. PubMed ID: 28107772
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Accuracy of Wearable Transdermal Alcohol Sensors: Systematic Review.
    Brobbin E; Deluca P; Hemrage S; Drummond C
    J Med Internet Res; 2022 Apr; 24(4):e35178. PubMed ID: 35436239
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Accuracy of transdermal alcohol monitoring devices in a laboratory setting.
    Brobbin E; Deluca P; Coulton S; Drummond C
    Alcohol Alcohol; 2024 Jan; 59(1):. PubMed ID: 37873967
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Folic acid supplementation and malaria susceptibility and severity among people taking antifolate antimalarial drugs in endemic areas.
    Crider K; Williams J; Qi YP; Gutman J; Yeung L; Mai C; Finkelstain J; Mehta S; Pons-Duran C; Menéndez C; Moraleda C; Rogers L; Daniels K; Green P
    Cochrane Database Syst Rev; 2022 Feb; 2(2022):. PubMed ID: 36321557
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Acceptability and Feasibility of Wearable Transdermal Alcohol Sensors: Systematic Review.
    Brobbin E; Deluca P; Hemrage S; Drummond C
    JMIR Hum Factors; 2022 Dec; 9(4):e40210. PubMed ID: 36563030
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Wrist-worn alcohol biosensors: Applications and usability in behavioral research.
    Wang Y; Fridberg DJ; Shortell DD; Leeman RF; Barnett NP; Cook RL; Porges EC
    Alcohol; 2021 May; 92():25-34. PubMed ID: 33609635
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Feasibility of a telehealth-based contingency management intervention for alcohol use disorders using the phosphatidylethanol (PEth) 16:0/18:1 alcohol biomarker: a pilot randomized trial.
    Jett JD; Beck R; Tyutyunnyk D; Sanchez J; Weeks DL; Javors MA; Hill-Kapturczak N; Lopez-Cruzan M; Kriegel L; Ginsburg BC; Cabassa L; McDonell MG
    Am J Drug Alcohol Abuse; 2024 Mar; 50(2):162-172. PubMed ID: 38284925
    [No Abstract]   [Full Text] [Related]  

  • 13. A prospective, randomized, single-blinded, crossover trial to investigate the effect of a wearable device in addition to a daily symptom diary for the remote early detection of SARS-CoV-2 infections (COVID-RED): a structured summary of a study protocol for a randomized controlled trial.
    Brakenhoff TB; Franks B; Goodale BM; van de Wijgert J; Montes S; Veen D; Fredslund EK; Rispens T; Risch L; Dowling AV; Folarin AA; Bruijning P; Dobson R; Heikamp T; Klaver P; Cronin M; Grobbee DE;
    Trials; 2021 Jun; 22(1):412. PubMed ID: 34158099
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Wearable alcohol monitors for alcohol use data collection among college students: Feasibility and acceptability.
    Rosenberg M; Kianersi S; Luetke M; Jozkowski K; Guerra-Reyes L; Shih PC; Finn P; Ludema C
    Alcohol; 2023 Sep; 111():75-83. PubMed ID: 37295566
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A Personalized Approach Bias Modification Smartphone App ("SWiPE") to Reduce Alcohol Use: Open-Label Feasibility, Acceptability, and Preliminary Effectiveness Study.
    Manning V; Piercy H; Garfield JBB; Clark SG; Andrabi MN; Lubman DI
    JMIR Mhealth Uhealth; 2021 Dec; 9(12):e31353. PubMed ID: 34890355
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A prospective, randomized, single-blinded, crossover trial to investigate the effect of a wearable device in addition to a daily symptom diary for the Remote Early Detection of SARS-CoV-2 infections (COVID-RED): a structured summary of a study protocol for a randomized controlled trial.
    Brakenhoff TB; Franks B; Goodale BM; van de Wijgert J; Montes S; Veen D; Fredslund EK; Rispens T; Risch L; Dowling AV; Folarin AA; Bruijning P; Dobson R; Heikamp T; Klaver P; Cronin M; Grobbee DE;
    Trials; 2021 Oct; 22(1):694. PubMed ID: 34635140
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Preoperative behavioural intervention to reduce drinking before elective orthopaedic surgery: the PRE-OP BIRDS feasibility RCT.
    Snowden C; Lynch E; Avery L; Haighton C; Howel D; Mamasoula V; Gilvarry E; McColl E; Prentis J; Gerrand C; Steel A; Goudie N; Howe N; Kaner E
    Health Technol Assess; 2020 Mar; 24(12):1-176. PubMed ID: 32131964
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A smoking cessation smartphone app that delivers real-time 'context aware' behavioural support: the Quit Sense feasibility RCT.
    Naughton F; Hope A; Siegele-Brown C; Grant K; Notley C; Colles A; West C; Mascolo C; Coleman T; Barton G; Shepstone L; Prevost T; Sutton S; Crane D; Greaves F; High J
    Public Health Res (Southampt); 2024 Apr; 12(4):1-99. PubMed ID: 38676391
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Transdermal alcohol concentration data collected during a contingency management program to reduce at-risk drinking.
    Dougherty DM; Karns TE; Mullen J; Liang Y; Lake SL; Roache JD; Hill-Kapturczak N
    Drug Alcohol Depend; 2015 Mar; 148():77-84. PubMed ID: 25582388
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A contingency management intervention to reduce cannabis use and time to relapse in early psychosis: the CIRCLE RCT.
    Johnson S; Rains LS; Marwaha S; Strang J; Craig T; Weaver T; McCrone P; King M; Fowler D; Pilling S; Marston L; Omar RZ; Craig M; Spencer J; Hinton M
    Health Technol Assess; 2019 Aug; 23(45):1-108. PubMed ID: 31460865
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.